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SYSTEMATIC REVIEW RELIABILITY: EFFICACY OF TWO INDEPENDENT
REVIEWERS AND TWO–STEP REVIEWS
Pietri G, Muston D
Heron Evidence Development Ltd, Stopsley, Luton, UK
OBJECTIVES: In a systematic review of literature, reviewing papers twice by two
reviewers improves the likelihood of correctly including/excluding citations. Also, 
reviewing ﬁ rst the abstract then the full text allows the reviewer to have had more
exposure to the literature, and thus to be more accurate in his decision. A statistical 
model was ﬁ tted and paired t-tests were performed to determine between-reviewer 
and between-review reliability and variation. METHODS: Inclusion/exclusion deci-
sions made by two reviewers at the abstract and the full-text reviews of six recently 
conducted systematic reviews (one economic and ﬁ ve clinical) were analysed and 
compared to the ﬁ nal inclusion/exclusion decision. For both reviewers, sensitivity (the
proportion of correctly included citations) and speciﬁ city (the proportion of correctly 
excluded citations) were modelled using bayesian Poisson regression. Paired t-tests
were performed to evaluate the improvements of sensitivity and speciﬁ city between 
the abstract and the full-text reviews. RESULTS: The sensitivity of reviewer two was
signiﬁ cantly higher in one out of six systematic reviews at abstract review, and in
another one at full-text review. Reviewer two’s speciﬁ city was also signiﬁ cantly higher 
in three systematic reviews at abstract review, and in one systematic review at full-text 
review. Reviewers were on average 89.6% sensitive and 95.7% speciﬁ c at including
or excluding publications at abstract review. At full-text review, the average sensitivity 
increased signiﬁ cantly (97.1%, p  0.006) whereas the speciﬁ city remained similar
(95.9%, p  0.81). CONCLUSIONS: While ﬁ rst and second reviewers tend to have
similar sensitivity in including citations at abstract review, reviewer two tends to be 
more accurate at excluding citations, thus increasing the likelihood of correctly exclud-
ing citations. At full-text review, sensitivity and speciﬁ city tend to be similar between
the two reviewers, but sensitivity increases signiﬁ cantly compared to abstract review. 
This shows that the full-text review provides further conﬁ rmation that the included 
citations are indeed relevant.
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SIGNIFICANCE OF INCORPORATING COMMUNITY–BASED DATA OF A
TARGET POPULATION INTO PHARMACOECONOMIC MODELS
Farahani P
Berkshire Medical Center, University of Massachusetts Medical School, Pittsﬁ eld, MA, USA
Community-based aspects of therapeutic can inﬂ uence the outcomes of pharmacoeco-
nomic evaluations. OBJECTIVES: To evaluate the effect of incorporating data from 
RCTs versus data from community clinical practices on the results of an economic
model of statins. METHODS: The beneﬁ t of reducing LDL-C was incorporated into 
a model to calculate reduction in cardiovascular events and resulted economic out-
comes. Data for LDL-C reduction from a head-to-head RCT [Am Heart J 
2002;144:1044–51] were obtained for rosuvastatin (starting 5 mg) versus atorvastatin
(starting 10 mg) with up-titration doses. A distribution of cardiovascular risk for users
[N  100,000, duration 5 years] in Canadian population [Clin Invest Med 2007;30:
E63-E69] was assumed. Then, to illustrate the signiﬁ cance of the population level data, 
the data from the Canadian community-based clinical practice settings was removed
from the model and the original RCT probability distribution for cardiovascular risk
strata was applied into the model. RESULTS: Using community-based data modelling 
rosuvastatin and atorvastatin can prevent 9505 and 8702 cardiovascular events (non-
fatal MI and stroke). Reduction in non-fatal MI and stroke can be translated to 
$252,300,392 (CDN), and $230,980,624 direct cost savings, respectively. Incorporat-
ing the RCT cardiovascular risk distribution, rosuvastatin and atorvastatin can 
prevent 7129 and 6712 cardiovascular events. This could lead to $180,214,565 and 
$178,152,982 direct cost savings for the Canadian health care system (adherence to 
therapy was assumed to be at the level of RCT). CONCLUSIONS: The distribution 
of cardiovascular risk was dissimilar between the RCT and the Canadian community-
based data. The proportion of low risk patients enrolled in the RCT was signiﬁ cantly
higher in comparison with the proportion of low risk patients on statin therapy in the 
Canadian community. Therefore, in this case the magnitude of cost savings would
considerably be reduced if the RCT data were incorporated into the model instead of 
the community-based data.
CONCEPTUAL PAPERS & RESEARCH ON METHODS – Cost Methods
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COMPARISON BETWEEN PROPENSITY SCORE AND TRADITIONAL 
COVARIATE ADJUSTMENT WITH LOGISTIC REGRESSION MODELS IN 
ESTIMATING THE AVERAGE TREATMENT EFFECTS (ATES): RESULTS
FROM MONTE CARLO SIMULATIONS
Le QA, Hay JW
University of Southern California, Los Angeles, CA, USA
OBJECTIVES: Several recent systematic reviews of published studies in clinical
research using both traditional covariate adjustment regression and propensity score 
(PS) methodology to control for confounding reported that both methods produced 
similar estimating results. In this study, we used Monte Carlo simulations to evaluate
performance of different models derived from the two methods. METHODS: Sixteen
dichotomous variables (X1 – X16) with different levels of association between treat-
ment and outcome were randomly and simultaneously generated from the independent 
Bernoulli distribution with a probability of 0.5. Twelve variables (X1, X2, X3, X5, 
X6, X7, X9, X10, X11, X13, X14, and X15) are associated with treatment assign-
ment; while (X1 – X12) are associated with the outcome; and X16 is neither associated 
with treatment assignment nor outcome. We investigated six models, of which two
models using traditional covariate adjustment with logistic regression (LR), one 
model without adjustment for confounders, and three models using PS as followed: 
(1) model 1: adjusted for 16 variables; (2) model 2: adjusted for 12 variables associated
with outcome; (3) model 3: no adjustment for confounders; (4) model 4: adjusted 
for the PS; (5) model 5: stratiﬁ ed on 5 quintiles of the PS; and (6) model 6: 4-digit 
match on the PS. RESULTS: The conventional covariate adjustment with LR (model
1 and 2) consistently and unbiasedly estimated the speciﬁ ed ATEs. Without covariate 
adjustment, model 3 produced biased estimations. Among all three PS models (models
4, 5, and 6), only model 6 resulted in unbiased estimation of the speciﬁ ed
ATEs. However, compared with traditional covariate adjustment with LR, model 6, 
though produced unbiased estimates, had larger variances. CONCLUSIONS: For 
dichotomous confounders, adjustment and stratiﬁ cation on the quintiles of the PS, 
though widely used in clinical research, produce biased estimations; while conven-
tional covariate adjustment with LR resulted in unbiased estimations with small 
variances.
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GROWTH, CHARACTERISTICS AND QUALITY OF THE COST–UTILITY
ANALYSIS LITERATURE THROUGH 2006
Greenberg D1, Fang C1, Cohen JT1, Eldar-Lissai A2, Neumann PJ1
1Tufts-New England Medical Center, Boston, MA, USA, 2University of Rochester, Rochester, 
NY, USA
OBJECTIVES: To describe the growth over time and methodological quality of cost-
utility analyses (CUAs) published in the peer-reviewed literature through 2006.
METHODS: This study updates and expands our previous work, which examined 
CUAs through 2003 (n  795). We systematically searched the English-language litera-
ture for original CUAs published through 2006 using Medline and other databases.
Two trained readers independently audited each study and collected data on a wide
variety of elements related to study origin, methods, and reporting of results. 
RESULTS: We identiﬁ ed 1431 original CUAs (currently included in the Tufts Medical 
Center Cost-Effectiveness Analysis Registry, www.cearegistry.org). The more than 200 
CUAs published annually from 2004 to 2006 nearly doubled the size of the CUA lit-
erature. Most analyses pertain to the U.S. (51%), followed by the U.K. (16%), and
Canada (7%). CUAs cover a wide range of disease areas, including cardiovascular 
diseases (15%), infectious diseases (14%), and cancer (13%), and examine interven-
tions for tertiary care (62%), secondary prevention (23%), and primary prevention 
(15%). Although most studies adhere to guidelines for conducting and reporting CUA 
results, their average quality (4.2 o 1.1 on a 1–7 Likert scale) did not change substan-
tially over time. Study quality was higher for CUAs published in experienced journals 
(publishing a total of q10 CUAs); (n  31 journals), vs. other (n  390 journals); (4.5 
o 1.1 vs. 3.9 o 1.1, respectively; p  0.0001), for CUAs evaluating pharmaceuticals 
vs. other interventions (4.3 o 1.0 vs. 4.1 o 1.2, respectively; p  0.0001), and for CUAs
supported by a government organization vs. other sponsors (4.4 o 1.0 vs. 4.1 o 1.2, 
respectively; p  0.0001). CONCLUSIONS: The rapid growth in published CUAs
demonstrates the increased role these analyses play in informing resource allocation 
decisions. Journals should conduct more rigorous reviews and assure adherence to
guidelines for conducting and reporting CUA results.
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VALIDATION OF HEALTH CARE RESOURCE USE
QUESTIONNAIRES IN MEXICO
Tenorio C1, Vargas J2, Ivanova S3, Martínez-Fonseca J3, Paladio Á3, Mould–Quevedo J4
1Instituto Nacional de Cancerología, Mexico, DF, Mexico, 2Econopharma Consulting SA de
CV, Mexico, DF, Mexico, 3Econopharma Consulting SA de CV, Mexico City, Mexico, 4Pﬁ zer 
Mexico, Mexico City, Mexico
OBJECTIVES: Current Mexican health care resource-use questionnaires are subjective 
and not validated through a scientiﬁ c technique. This generates heterogeneity in costs
obtained from several economic evaluations(EE), uneasy to compare methodologically 
and useless to include in future EE alongside clinical trials. The objective of this study 
was to develop and validate three instruments to assess resource utilization from the
societal perspective. METHODS: Three speciﬁ c instruments were constructed for 
patients with cardiovascular diseases (hypertension and acute myocardial infarction); 
oncological (breast, renal and lung cancer) and HIV/AIDS with the aid of a special
Mexican consensus. Instruments were subdivided into two sections: recover medical 
data from hospital records and a survey with patients. The latter was applied to adult 
Mexican patients from the Social Security Mexican Institute(IMSS) between June and
October 2008. Instruments include ﬁ ve dimensions:(diagnostic, treatment and medical 
follow-up, support services, clinical data and epidemiological data) and pretend to be 
helpful to obtain direct costs (data collected from hospital records); and indirect and 
out-of-pocket expenses (data collected from the patient). Sample size estimate used
epidemiological Mexican data and statistical tests were performed to demonstrated
internal consistency reliability (Cronbach’s alpha), interclass correlation coefﬁ cient,
component analysis (parametric bootstrapping) and construct validity was also evalu-
ated. RESULTS: A total of 213 patients were included in the study (31.9% cardiovas-
cular, 30.0% oncological; 38.1% HIV/AIDS). Mean age of participants was 54.9 o
9.08 years; 49.3% were female. Internal consistency was found in all questionnaires:
Cronbach’s alpha reported range for cardiovascular patients from 0.73–0.78; cancer 
patients 0.67–0.80, and HIV/AIDS patients from 0.82–0.87. Higher internal consis-
